 | • レポートコード：QY20ST-09787 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の免疫サイトカイン市場について種類別（肝臓、視床下部、脂肪筋、B・Tリンパ球、骨髄内皮）、用途別（Tumors and Cancer、 Rheumatoid Arthritis）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・免疫サイトカイン市場の概要 ・世界の主要地域別免疫サイトカイン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の免疫サイトカイン市場規模2015-2026：種類別（肝臓、視床下部、脂肪筋、B・Tリンパ球、骨髄内皮） ・世界の免疫サイトカイン市場規模2015-2026：用途別（Tumors and Cancer、 Rheumatoid Arthritis） ・免疫サイトカインの北米市場規模2015-2020 ・免疫サイトカインのヨーロッパ市場規模2015-2020 ・免疫サイトカインの中国市場規模2015-2020 ・免疫サイトカインの日本市場規模2015-2020 ・免疫サイトカインの東南アジア市場規模2015-2020 ・免疫サイトカインのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・免疫サイトカインの製造コスト分析 ・販売チャネル、流通業者、顧客 ・免疫サイトカインの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Immunocytokines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Immunocytokines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Immunocytokines (ICs) are a class of molecules created by linking tumor-reactive monoclonal antibodies to cytokines that are able to activate immune cells.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Immunocytokines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Immunocytokines industry.
Based on our recent survey, we have several different scenarios about the Immunocytokines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Immunocytokines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Immunocytokines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Immunocytokines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Immunocytokines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Immunocytokines market. The report also includes nautical information, where it shows Immunocytokines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Immunocytokines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Immunocytokines market.
Geographical Analysis:
Based on region, the global Immunocytokines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Immunocytokines market are
Alkermes Plc
AstraZeneca Plc
CytImmune
Cytune Pharma
Altor Biosciences Corporation
Apeiron Biologics AG
Paladin Labs
Teva Pharmaceutical Industries Ltd.
Valor Biotherapeutics
Targa Therapeutics Corporation
Immunomedics, Inc.
ImmunGene, Inc.
MolMed S.p.A.
Merck KGaA
Nektar Therapeutics
Pfizer, Inc.
F. Hoffmann-La Roche, Ltd.
Segment by Type
Liver
Hypothalamus
Fat muscle
B and T lymphocytes
Bone Marrow Endothelium
Segment by Application
Tumors and Cancer
Rheumatoid Arthritis
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Immunocytokines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Immunocytokines market.
• The market share of the global Immunocytokines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Immunocytokines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Immunocytokines market.
1 Immunocytokines Market Overview
1.1 Immunocytokines Product Scope
1.2 Immunocytokines Segment by Type
1.2.1 Global Immunocytokines Sales by Type (2020-2026)
1.2.2 Liver
1.2.3 Hypothalamus
1.2.4 Fat muscle
1.2.5 B and T lymphocytes
1.2.6 Bone Marrow Endothelium
1.3 Immunocytokines Segment by Application
1.3.1 Global Immunocytokines Sales Comparison by Application (2020-2026)
1.3.2 Tumors and Cancer
1.3.3 Rheumatoid Arthritis
1.4 Immunocytokines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Immunocytokines Sales Growth Rate (2015-2026)
1.4.2 Global Immunocytokines Revenue and Growth Rate (2015-2026)
1.4.3 Global Immunocytokines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Immunocytokines Industry Impact
1.5.1 How the Covid-19 is Affecting the Immunocytokines Industry
1.5.1.1 Immunocytokines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Immunocytokines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Immunocytokines Players to Combat Covid-19 Impact
2 Immunocytokines Estimate and Forecast by Region
2.1 Global Immunocytokines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Immunocytokines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Immunocytokines Sales Market Share by Region (2015-2020)
2.2.2 Global Immunocytokines Revenue Market Share by Region (2015-2020)
2.3 Global Immunocytokines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Immunocytokines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Immunocytokines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Immunocytokines Estimates and Projections (2015-2026)
2.4.2 Europe Immunocytokines Estimates and Projections (2015-2026)
2.4.3 China Immunocytokines Estimates and Projections (2015-2026)
2.4.4 Japan Immunocytokines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Immunocytokines Estimates and Projections (2015-2026)
2.4.6 India Immunocytokines Estimates and Projections (2015-2026)
3 Global Immunocytokines Competition Landscape by Players
3.1 Global Top Immunocytokines Players by Sales (2015-2020)
3.2 Global Top Immunocytokines Players by Revenue (2015-2020)
3.3 Global Immunocytokines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunocytokines as of 2019)
3.4 Global Immunocytokines Average Price by Company (2015-2020)
3.5 Manufacturers Immunocytokines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Immunocytokines Players (Opinion Leaders)
4 Global Immunocytokines Market Size by Type
4.1 Global Immunocytokines Historic Market Review by Type (2015-2020)
4.1.1 Global Immunocytokines Sales Market Share by Type (2015-2020)
4.1.2 Global Immunocytokines Revenue Market Share by Type (2015-2020)
4.1.3 Global Immunocytokines Price by Type (2014-2020)
4.2 Global Immunocytokines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Immunocytokines Sales Forecast by Type (2021-2026)
4.2.2 Global Immunocytokines Revenue Forecast by Type (2021-2026)
4.2.3 Global Immunocytokines Price Forecast by Type (2021-2026)
5 Global Immunocytokines Market Size by Application
5.1 Global Immunocytokines Historic Market Review by Application (2015-2020)
5.1.1 Global Immunocytokines Sales Market Share by Application (2015-2020)
5.1.2 Global Immunocytokines Revenue Market Share by Application (2015-2020)
5.1.3 Global Immunocytokines Price by Application (2015-2020)
5.2 Global Immunocytokines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Immunocytokines Sales Forecast by Application (2021-2026)
5.2.2 Global Immunocytokines Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunocytokines Price Forecast by Application (2021-2026)
3 North America Immunocytokines Market Facts & Figures
3.2 North America Immunocytokines Sales Market Share by Company (2015-2020)
3.3 North America Immunocytokines Sales Market Share by Type (2015-2020)
3.4 North America Immunocytokines Sales Market Share by Application (2015-2020)
4 Europe Immunocytokines Market Facts & Figures
4.2 Europe Immunocytokines Sales Market Share by Company (2015-2020)
4.3 Europe Immunocytokines Sales Market Share by Type (2015-2020)
4.4 Europe Immunocytokines Sales Market Share by Application (2015-2020)
5 China Immunocytokines Market Facts & Figures
5.2 China Immunocytokines Sales Market Share by Company (2015-2020)
5.3 China Immunocytokines Sales Market Share by Type (2015-2020)
5.4 China Immunocytokines Sales Market Share by Application (2015-2020)
6 Japan Immunocytokines Market Facts & Figures
6.2 Japan Immunocytokines Sales Market Share by Company (2015-2020)
6.3 Japan Immunocytokines Sales Market Share by Type (2015-2020)
6.4 Japan Immunocytokines Sales Market Share by Application (2015-2020)
7 Southeast Asia Immunocytokines Market Facts & Figures
7.2 Southeast Asia Immunocytokines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Immunocytokines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Immunocytokines Sales Market Share by Application (2015-2020)
8 India Immunocytokines Market Facts & Figures
8.2 India Immunocytokines Sales Market Share by Company (2015-2020)
8.3 India Immunocytokines Sales Market Share by Type (2015-2020)
8.4 India Immunocytokines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Immunocytokines Business
12.1 Alkermes Plc
12.1.1 Alkermes Plc Immunocytokines Corporation Information
12.1.2 Alkermes Plc Immunocytokines Business Overview and Total Revenue
12.1.3 Alkermes Plc Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Alkermes Plc Immunocytokines Products Offered
12.1.5 Alkermes Plc Recent Development
12.2 AstraZeneca Plc
12.2.1 AstraZeneca Plc Immunocytokines Corporation Information
12.2.2 AstraZeneca Plc Immunocytokines Business Overview and Total Revenue
12.2.3 AstraZeneca Plc Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Plc Immunocytokines Products Offered
12.2.5 AstraZeneca Plc Recent Development
12.3 CytImmune
12.3.1 CytImmune Immunocytokines Corporation Information
12.3.2 CytImmune Immunocytokines Business Overview and Total Revenue
12.3.3 CytImmune Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CytImmune Immunocytokines Products Offered
12.3.5 CytImmune Recent Development
12.4 Cytune Pharma
12.4.1 Cytune Pharma Immunocytokines Corporation Information
12.4.2 Cytune Pharma Immunocytokines Business Overview and Total Revenue
12.4.3 Cytune Pharma Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cytune Pharma Immunocytokines Products Offered
12.4.5 Cytune Pharma Recent Development
12.5 Altor Biosciences Corporation
12.5.1 Altor Biosciences Corporation Immunocytokines Corporation Information
12.5.2 Altor Biosciences Corporation Immunocytokines Business Overview and Total Revenue
12.5.3 Altor Biosciences Corporation Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Altor Biosciences Corporation Immunocytokines Products Offered
12.5.5 Altor Biosciences Corporation Recent Development
12.6 Apeiron Biologics AG
12.6.1 Apeiron Biologics AG Immunocytokines Corporation Information
12.6.2 Apeiron Biologics AG Immunocytokines Business Overview and Total Revenue
12.6.3 Apeiron Biologics AG Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Apeiron Biologics AG Immunocytokines Products Offered
12.6.5 Apeiron Biologics AG Recent Development
12.7 Paladin Labs
12.7.1 Paladin Labs Immunocytokines Corporation Information
12.7.2 Paladin Labs Immunocytokines Business Overview and Total Revenue
12.7.3 Paladin Labs Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Paladin Labs Immunocytokines Products Offered
12.7.5 Paladin Labs Recent Development
12.8 Teva Pharmaceutical Industries Ltd.
12.8.1 Teva Pharmaceutical Industries Ltd. Immunocytokines Corporation Information
12.8.2 Teva Pharmaceutical Industries Ltd. Immunocytokines Business Overview and Total Revenue
12.8.3 Teva Pharmaceutical Industries Ltd. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Pharmaceutical Industries Ltd. Immunocytokines Products Offered
12.8.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.9 Valor Biotherapeutics
12.9.1 Valor Biotherapeutics Immunocytokines Corporation Information
12.9.2 Valor Biotherapeutics Immunocytokines Business Overview and Total Revenue
12.9.3 Valor Biotherapeutics Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Valor Biotherapeutics Immunocytokines Products Offered
12.9.5 Valor Biotherapeutics Recent Development
12.10 Targa Therapeutics Corporation
12.10.1 Targa Therapeutics Corporation Immunocytokines Corporation Information
12.10.2 Targa Therapeutics Corporation Immunocytokines Business Overview and Total Revenue
12.10.3 Targa Therapeutics Corporation Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Targa Therapeutics Corporation Immunocytokines Products Offered
12.10.5 Targa Therapeutics Corporation Recent Development
12.11 Immunomedics, Inc.
12.11.1 Immunomedics, Inc. Immunocytokines Corporation Information
12.11.2 Immunomedics, Inc. Immunocytokines Business Overview and Total Revenue
12.11.3 Immunomedics, Inc. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Immunomedics, Inc. Immunocytokines Products Offered
12.11.5 Immunomedics, Inc. Recent Development
12.12 ImmunGene, Inc.
12.12.1 ImmunGene, Inc. Immunocytokines Corporation Information
12.12.2 ImmunGene, Inc. Immunocytokines Business Overview and Total Revenue
12.12.3 ImmunGene, Inc. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 ImmunGene, Inc. Immunocytokines Products Offered
12.12.5 ImmunGene, Inc. Recent Development
12.13 MolMed S.p.A.
12.13.1 MolMed S.p.A. Immunocytokines Corporation Information
12.13.2 MolMed S.p.A. Immunocytokines Business Overview and Total Revenue
12.13.3 MolMed S.p.A. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 MolMed S.p.A. Immunocytokines Products Offered
12.13.5 MolMed S.p.A. Recent Development
12.14 Merck KGaA
12.14.1 Merck KGaA Immunocytokines Corporation Information
12.14.2 Merck KGaA Immunocytokines Business Overview and Total Revenue
12.14.3 Merck KGaA Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Merck KGaA Immunocytokines Products Offered
12.14.5 Merck KGaA Recent Development
12.15 Nektar Therapeutics
12.15.1 Nektar Therapeutics Immunocytokines Corporation Information
12.15.2 Nektar Therapeutics Immunocytokines Business Overview and Total Revenue
12.15.3 Nektar Therapeutics Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Nektar Therapeutics Immunocytokines Products Offered
12.15.5 Nektar Therapeutics Recent Development
12.16 Pfizer, Inc.
12.16.1 Pfizer, Inc. Immunocytokines Corporation Information
12.16.2 Pfizer, Inc. Immunocytokines Business Overview and Total Revenue
12.16.3 Pfizer, Inc. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Pfizer, Inc. Immunocytokines Products Offered
12.16.5 Pfizer, Inc. Recent Development
12.17 F. Hoffmann-La Roche, Ltd.
12.17.1 F. Hoffmann-La Roche, Ltd. Immunocytokines Corporation Information
12.17.2 F. Hoffmann-La Roche, Ltd. Immunocytokines Business Overview and Total Revenue
12.17.3 F. Hoffmann-La Roche, Ltd. Immunocytokines Sales, Revenue and Gross Margin (2015-2020)
12.17.4 F. Hoffmann-La Roche, Ltd. Immunocytokines Products Offered
12.17.5 F. Hoffmann-La Roche, Ltd. Recent Development
13 Immunocytokines Manufacturing Cost Analysis
13.1 Immunocytokines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immunocytokines
13.4 Immunocytokines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immunocytokines Distributors List
14.3 Immunocytokines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Immunocytokines Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Immunocytokines Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Immunocytokines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Immunocytokines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Immunocytokines Players to Combat Covid-19 Impact
Table 8. Global Market Immunocytokines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Immunocytokines Sales (MT) by Region (2015-2020)
Table 10. Global Immunocytokines Sales Market Share by Region (2015-2020)
Table 11. Global Immunocytokines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Immunocytokines Revenue Share by Region (2015-2020)
Table 13. Global Immunocytokines Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Immunocytokines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Immunocytokines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Immunocytokines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Immunocytokines (MT) of Key Companies (2015-2020)
Table 18. Global Immunocytokines Sales Share by Company (2015-2020)
Table 19. Global Immunocytokines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Immunocytokines Revenue Share by Company (2015-2020)
Table 21. Global Immunocytokines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunocytokines as of 2019)
Table 22. Global Immunocytokines Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Immunocytokines Manufacturing Sites and Area Served
Table 24. Manufacturers Immunocytokines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Immunocytokines Players
Table 27. Global Immunocytokines Sales (MT) by Type (2015-2020)
Table 28. Global Immunocytokines Sales Share by Type (2015-2020)
Table 29. Global Immunocytokines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Immunocytokines Price (MT) by Type (2015-2020)
Table 31. Global Immunocytokines Sales Share by Type (2021-2026)
Table 32. Global Immunocytokines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Immunocytokines Revenue Share by Type (2021-2026)
Table 34. Global Immunocytokines Price (MT) by Type (2021-2026)
Table 35. Global Immunocytokines Sales (MT) by Application (2015-2020)
Table 36. Global Immunocytokines Sales Share by Application (2015-2020)
Table 37. Global Immunocytokines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Immunocytokines Price (MT) by Application (2015-2020)
Table 39. Global Immunocytokines Sales (MT) by Application (2021-2026)
Table 40. Global Immunocytokines Sales Share by Application (2021-2026)
Table 41. Global Immunocytokines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Immunocytokines Revenue Share by Application (2021-2026)
Table 43. Global Immunocytokines Price (MT) by Application (2021-2026)
Table 44. United States Immunocytokines Sales (MT) by Company (2015-2020)
Table 45. United States Immunocytokines Sales Market Share by Company (2015-2020)
Table 46. United States Immunocytokines Sales (MT) by Type (2015-2020)
Table 47. United States Immunocytokines Sales Market Share by Type (2015-2020)
Table 48. United States Immunocytokines Sales (MT) by Application (2015-2020)
Table 49. United States Immunocytokines Sales Market Share by Application (2015-2020)
Table 50. Europe Immunocytokines Sales (MT) by Company (2015-2020)
Table 51. Europe Immunocytokines Sales Market Share by Company (2015-2020)
Table 52. Europe Immunocytokines Sales (MT) by Type (2015-2020)
Table 53. Europe Immunocytokines Sales Market Share by Type (2015-2020)
Table 54. Europe Immunocytokines Sales (MT) by Application (2015-2020)
Table 55. Europe Immunocytokines Sales Market Share by Type (2015-2020)
Table 56. China Immunocytokines Sales (MT) by Company (2015-2020)
Table 57. China Immunocytokines Sales Market Share by Company (2015-2020)
Table 58. China Immunocytokines Sales (MT) by Type (2015-2020)
Table 59. China Immunocytokines Sales Market Share by Type (2015-2020)
Table 60. China Immunocytokines Sales (MT) by Application (2015-2020)
Table 61. China Immunocytokines Sales Market Share by Application (2015-2020)
Table 62. Japan Immunocytokines Sales (MT) by Company (2015-2020)
Table 63. Japan Immunocytokines Sales Market Share by Company (2015-2020)
Table 64. Japan Immunocytokines Sales (MT) by Type (2015-2020)
Table 65. Japan Immunocytokines Sales Market Share by Type (2015-2020)
Table 66. Japan Immunocytokines Sales (MT) by Application (2015-2020)
Table 67. Japan Immunocytokines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Immunocytokines Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Immunocytokines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Immunocytokines Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Immunocytokines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Immunocytokines Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Immunocytokines Sales Market Share by Application (2015-2020)
Table 74. India Immunocytokines Sales (MT) by Company (2015-2020)
Table 75. India Immunocytokines Sales Market Share by Company (2015-2020)
Table 76. India Immunocytokines Sales (MT) by Type (2015-2020)
Table 77. India Immunocytokines Sales Market Share by Type (2015-2020)
Table 78. India Immunocytokines Sales (MT) by Application (2015-2020)
Table 79. India Immunocytokines Sales Market Share by Application (2015-2020)
Table 80. Alkermes Plc Corporation Information
Table 81. Alkermes Plc Description and Business Overview
Table 82. Alkermes Plc Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Alkermes Plc Immunocytokines Product
Table 84. Alkermes Plc Recent Development
Table 85. AstraZeneca Plc Corporation Information
Table 86. AstraZeneca Plc Description and Business Overview
Table 87. AstraZeneca Plc Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. AstraZeneca Plc Immunocytokines Product
Table 89. AstraZeneca Plc Recent Development
Table 90. CytImmune Corporation Information
Table 91. CytImmune Description and Business Overview
Table 92. CytImmune Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. CytImmune Immunocytokines Product
Table 94. CytImmune Recent Development
Table 95. Cytune Pharma Corporation Information
Table 96. Cytune Pharma Description and Business Overview
Table 97. Cytune Pharma Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Cytune Pharma Immunocytokines Product
Table 99. Cytune Pharma Recent Development
Table 100. Altor Biosciences Corporation Corporation Information
Table 101. Altor Biosciences Corporation Description and Business Overview
Table 102. Altor Biosciences Corporation Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Altor Biosciences Corporation Immunocytokines Product
Table 104. Altor Biosciences Corporation Recent Development
Table 105. Apeiron Biologics AG Corporation Information
Table 106. Apeiron Biologics AG Description and Business Overview
Table 107. Apeiron Biologics AG Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Apeiron Biologics AG Immunocytokines Product
Table 109. Apeiron Biologics AG Recent Development
Table 110. Paladin Labs Corporation Information
Table 111. Paladin Labs Description and Business Overview
Table 112. Paladin Labs Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Paladin Labs Immunocytokines Product
Table 114. Paladin Labs Recent Development
Table 115. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 116. Teva Pharmaceutical Industries Ltd. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 118. Teva Pharmaceutical Industries Ltd. Immunocytokines Product
Table 119. Teva Pharmaceutical Industries Ltd. Recent Development
Table 120. Valor Biotherapeutics Corporation Information
Table 121. Valor Biotherapeutics Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Valor Biotherapeutics Description and Business Overview
Table 123. Valor Biotherapeutics Immunocytokines Product
Table 124. Valor Biotherapeutics Recent Development
Table 125. Targa Therapeutics Corporation Corporation Information
Table 126. Targa Therapeutics Corporation Description and Business Overview
Table 127. Targa Therapeutics Corporation Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Targa Therapeutics Corporation Immunocytokines Product
Table 129. Targa Therapeutics Corporation Recent Development
Table 130. Immunomedics, Inc. Corporation Information
Table 131. Immunomedics, Inc. Description and Business Overview
Table 132. Immunomedics, Inc. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Immunomedics, Inc. Immunocytokines Product
Table 134. Immunomedics, Inc. Recent Development
Table 135. ImmunGene, Inc. Corporation Information
Table 136. ImmunGene, Inc. Description and Business Overview
Table 137. ImmunGene, Inc. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. ImmunGene, Inc. Immunocytokines Product
Table 139. ImmunGene, Inc. Recent Development
Table 140. MolMed S.p.A. Corporation Information
Table 141. MolMed S.p.A. Description and Business Overview
Table 142. MolMed S.p.A. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. MolMed S.p.A. Immunocytokines Product
Table 144. MolMed S.p.A. Recent Development
Table 145. Merck KGaA Corporation Information
Table 146. Merck KGaA Description and Business Overview
Table 147. Merck KGaA Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Merck KGaA Immunocytokines Product
Table 149. Merck KGaA Recent Development
Table 150. Nektar Therapeutics Corporation Information
Table 151. Nektar Therapeutics Description and Business Overview
Table 152. Nektar Therapeutics Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Nektar Therapeutics Immunocytokines Product
Table 154. Nektar Therapeutics Recent Development
Table 155. Pfizer, Inc. Corporation Information
Table 156. Pfizer, Inc. Description and Business Overview
Table 157. Pfizer, Inc. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 158. Pfizer, Inc. Immunocytokines Product
Table 159. Pfizer, Inc. Recent Development
Table . F. Hoffmann-La Roche, Ltd. Corporation Information
Table . F. Hoffmann-La Roche, Ltd. Description and Business Overview
Table . F. Hoffmann-La Roche, Ltd. Immunocytokines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . F. Hoffmann-La Roche, Ltd. Immunocytokines Product
Table . F. Hoffmann-La Roche, Ltd. Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Immunocytokines Distributors List
Table 168. Immunocytokines Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunocytokines Product Picture
Figure 2. Global Immunocytokines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Immunocytokines Market Share by Application in 2020 & 2026
Figure 6. Tumors and Cancer Examples
Figure 7. Rheumatoid Arthritis Examples
Figure 8. Global Immunocytokines Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Immunocytokines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Immunocytokines Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Immunocytokines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Immunocytokines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Immunocytokines Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Immunocytokines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Immunocytokines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Immunocytokines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Immunocytokines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Immunocytokines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Immunocytokines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Immunocytokines Players Market Share by Revenue in Immunocytokines 2015 & 2019
Figure 26. Immunocytokines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Immunocytokines Revenue Share by Type (2015-2020)
Figure 28. Global Immunocytokines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Immunocytokines Revenue Share by Application (2015-2020)
Figure 30. Global Immunocytokines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Immunocytokines Sales Market Share by Type in 2019
Figure 32. United States Immunocytokines Sales Market Share by Type in 2019
Figure 33. Europe Immunocytokines Sales Market Share by Company in 2019
Figure 34. Europe Immunocytokines Sales Market Share by Type in 2019
Figure 35. Europe Immunocytokines Sales Market Share by Application in 2019
Figure 36. China Immunocytokines Sales Market Share by Company in 2019
Figure 37. China Immunocytokines Sales Market Share by Type in 2019
Figure 38. China Immunocytokines Sales Market Share by Application in 2019
Figure 39. Japan Immunocytokines Sales Market Share by Company in 2019
Figure 40. Japan Immunocytokines Sales Market Share by Type in 2019
Figure 41. Japan Immunocytokines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Immunocytokines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Immunocytokines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Immunocytokines Sales Market Share by Application in 2019
Figure 45. India Immunocytokines Sales Market Share by Company in 2019
Figure 46. India Immunocytokines Sales Market Share by Type in 2019
Figure 47. India Immunocytokines Sales Market Share by Application in 2019
Figure 48. Alkermes Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. AstraZeneca Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CytImmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Cytune Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Altor Biosciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Apeiron Biologics AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Paladin Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Valor Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Targa Therapeutics Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Immunomedics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. ImmunGene, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. MolMed S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Nektar Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. F. Hoffmann-La Roche, Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Immunocytokines
Figure 67. Manufacturing Process Analysis of Immunocytokines
Figure 68. Immunocytokines Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
骨髄生検針の世界市場レポート2020 A recently published report by QY Research titled Global Bone Marrow Biopsy Needles Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …- 関節リウマチ薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Rheumatoid Arthritis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 23310 million by 2025, from USD 20320 million in 2019. The Drugs f…
- 骨がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 65910 million by 2025, from USD 56730 million in 2019. The Bone Cancer market report …
- 電気筋刺激の世界市場レポート2020 A recently published report by QY Research titled Global Electrical muscle stimulation Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…
- 関節炎用関節内補充療法の世界市場レポート2020 A recently published report by QY Research titled Global Viscosupplementation Treatment for Arthritis Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…